Previous Article | Next Article 
Journal of Virology, October 2001, p. 9156-9164, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9156-9164.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is
Critical for Human Immunodeficiency Virus Type 1 RNA Dimer
Maturation
M.
Shehu-Xhilaga,1,2
H. G.
Kraeusslich,3
S.
Pettit,4
R.
Swanstrom,5
J. Y.
Lee,6
J. A.
Marshall,6
S. M.
Crowe,1,2 and
J.
Mak1,7,*
AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre
for Medical Research, Fairfield,
Victoria,1 Victorian Infectious
Diseases Reference Laboratory, North Melbourne,
Victoria,6 and Department of
Biochemistry and Molecular Biology7 and
Department of Medicine,2 Monash
University, Clayton, Victoria, Australia; Abteilung
Virologie, Universität Heidelberg, Heidelberg,
Germany3; and Department of Biochemistry
and Biophysics5 and Department of
Medicine, Infectious Diseases,4 University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina
27599
Received 22 January 2001/Accepted 25 June 2001
 |
ABSTRACT |
Differences in virion RNA dimer stability between mature and
protease-defective (immature) forms of human immunodeficiency virus
type 1 (HIV-1) suggest that maturation of the viral RNA dimer is
regulated by the proteolytic processing of the HIV-1 Gag and Gag-Pol
precursor proteins. However, the proteolytic processing of these
proteins occurs in several steps denoted primary, secondary, and
tertiary cleavage events and, to date, the processing step associated
with formation of stable HIV-1 RNA dimers has not been identified. We
show here that a mutation in the primary cleavage site (p2/nucleocapsid
[NC]) hinders formation of stable virion RNA dimers, while dimer
stability is unaffected by mutations in the secondary (matrix/capsid
[CA], p1/p6) or a tertiary cleavage site (CA/p2). By introducing
mutations in a shared cleavage site of either Gag or Gag-Pol, we also
show that the cleavage of the p2/NC site in Gag is more important for
dimer formation and stability than p2/NC cleavage in Gag-Pol. Electron
microscopy analysis of viral particles shows that mutations in the
primary cleavage site in Gag but not in Gag-Pol inhibit viral particle
maturation. We conclude that virion RNA dimer maturation is dependent
on proteolytic processing of the primary cleavage site and is
associated with virion core formation.
 |
INTRODUCTION |
The human immunodeficiency virus
type 1 (HIV-1) positive-stranded RNA genome, which forms a dimer within
the virion, is part of a ribonucleoprotein (RNP) complex encased in a
capsid shell and enveloped in the viral membrane studded with
glycoproteins. HIV-1 virions are initially produced as immature
particles that undergo maturation during or shortly after budding from
the plasma membrane (12). The immature virion does not
contain the internal core structure found in mature virions but instead
has a thick electron-dense spherical structure directly underneath the
virion envelope (31). Conversion of immature to mature
virions is termed maturation, and it requires proteolytic cleavage of
the HIV-1 structural polyproteins Gag and Gag-Pol by viral protease
(PR). This proteolysis is initiated at the membrane of the infected cell during virion budding and release and improves the release of
progeny viruses (30).
The main structural proteins of retroviruses are synthesized as a
single polyprotein, which in the case of HIV-1 is called Gag or
Pr55gag (48). The viral
replication enzymes PR, reverse transcriptase (RT), and integrase (IN)
are synthesized as a second polyprotein, Gag-Pol, which is N terminally
colinear with Gag and is derived from ribosomal frameshifting at a rate
of 5% (28). These polyproteins associate with other viral
proteins and genomic RNA to form the immature virion. Within the
virion, Gag is cleaved into matrix (MA), capsid (CA), nucleocapsid
(NC), p6, and two spacer peptides, p2 and p1. Gag-Pol also contains MA
and CA but its C-terminal cleavage products are p2, NC, transframe
protein (TF), PR, RT, and IN (Fig. 1).
The substrate specificity and the kinetics of cleavage by HIV-1
protease have previously been described (26, 41, 44).
Cleavage sites differ in their amino acid composition, but in all cases
the minimum substrate length required to permit cleavage by PR is
roughly 7 amino acids (aa) (7). Many of these sites are
distributed close to the CA region encoded by
Pr55gag. Cleavage of CA from its neighbors
within Gag polyprotein is necessary for core condensation and conical
capsid shell formation during virion maturation (50, 51).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of sequential proteolytic
processing of HIV-1 Gag (G) and Gag-Pol (GP) precursor proteins by
viral PR and the initial proteolysis rate of the primary (1°),
secondary (2°), and tertiary (3°) cleavage sites of Gag (slower)
adapted from Pettit et al. (42, 43). The scissors symbol
represents corresponding locations cut by PR in HIV-1. In this study,
constructs containing mutations that do not allow the processing of the
primary (p2/NC), secondary (MA/CA and p1/p6), and tertiary (CA/p2)
cleavage sites, from two different sources, were analyzed for their
protein profiles and genomic RNA dimer maturation.
|
|
Cleavage of Gag and Gag-Pol is essential for maturation and HIV-1
infectivity; mutation or inhibition of PR abolishes production of
infectious viruses (42, 51). The order and contribution of
individual cleavages have been studied in a cell-free system, as well
as in tissue culture systems. These studies have revealed that in
HIV-1, the proteolytic processing of Gag occurs in an orderly fashion
with primary, secondary, and tertiary sites being sequentially cleaved
by PR (Fig. 1) (43, 51). Gag proteolysis is thought to be
regulated, in part, by the cleavage of the p2 spacer peptide
(43). This peptide has also been shown in a cell-free system to act as the morphologic switch region during maturation of the
virus particle (19). Moreover, using the protease
inhibitor Ro 31-8959, Lindhofer et al. (35) have observed
production of intermediate products via autolytic processing of Gag-Pol
precursor protein, suggesting that the cleavage of Gag-Pol also occurs
in a defined sequence (Fig. 1).
During viral particle maturation, the packaging and rearrangement of
the genomic RNA rely on RNA-protein interactions (3, 36).
A chaperone activity for Gag protein has been described (16). In addition, the NC sequence within Gag protein
binds to genomic RNA and facilitates RNA packaging (5, 13,
23). In HIV-1, at least one zinc finger of the NC is required
for efficient RNA packaging to occur (4, 5, 11). Mutations
in the first zinc finger markedly reduce genomic RNA packaging into
virions, while mutations in the second zinc finger only decrease RNA
packaging by 30% (22).
Genomic RNA packaged in HIV-1 virions is dimeric. The inactivation of
viral protease decreases the stability of the RNA dimer, suggesting
that proteolytic processing and RNA dimer maturation are interrelated
(18, 19). In addition, deletion of the dimer initiation
sequence, a region essential for RNA dimerization, results in delayed
processing of p2 from CA and is associated with a reduction in virus
infectivity (33, 34). Other authors have suggested that
noncoding viral RNA leader sequences may also accelerate proteolytic
processing of the precursor proteins (47; for a review,
see reference 50). In other retroviruses, e.g., Rous
sarcoma virus, mutation of NC leads to the production of noninfectious
Rous sarcoma virus, which contains unstable virion RNA dimers
(39; for a review, see reference 31).
Moreover, whether in its mature (p7) or precursor (p15) form, HIV-1 NC
induces maturation of retroviral dimeric RNA in a cell-free system
(16, 17, 40). From these studies it appears likely that
the NC sequence within Gag or the mature NC itself stabilizes HIV-1 RNA dimers. However, the involvement of HIV-1 NC in RNA dimerization during
viral assembly has not been directly examined.
We report here that a mutation in the primary cleavage site (p2/NC) of
the HIV-1 genome which prevents the cleavage of CA-p2 from NC markedly
decreases genomic RNA dimer stability. Mutations in the secondary
(MA/CA and p1/p6) and tertiary (CA/p2) cleavage sites do not alter RNA
dimer stability, suggesting that stable RNA dimer formation occurs
either simultaneously or immediately after proteolysis at the primary
cleavage site of Gag. In addition, using a cotransfection system, we
show that for HIV-1 the cleavage of the p2/NC site in Gag is more
important than cleavage of the same site in Gag-Pol for RNA
dimerization and the condensation of the virion core. This study
suggests that the free N terminus of NC is likely to be important for
virion RNA dimer maturation and virion core capsid formation.
 |
MATERIALS AND METHODS |
DNA plasmids.
The cleavage site HIV-1 mutants MA/CA, p1/p6,
and CA/p2, containing a P1 Ile substitution that inhibits cleavage,
were previously described by Pettit et al. (42). A
full-length HIV-1 proviral clone, NL4.3, was used as a control. The
single cleavage site mutant CA2 (p2/NC), double cleavage site mutant
CA5 (CA/p2 and a CA cryptic site mutation), and triple cleavage site
mutant CA6 (p2/NC-CA/p2-cryptic site mutation) have been previously
described by Wiegers et al. (51; see Table
1 for details). For the cotransfection study, the full-length wild-type (WT) HIV-1 plasmid used was HXB2-BH10 (49). The Gag-Pol expression plasmid (GP) was constructed
using PCR stitch mutagenesis as previously described (37).
The frameshift mutation in GP allows continuous expression of Gag-Pol
and bypasses the Gag termination codon. The
GagUAA (G) plasmid was also constructed by using
PCR stitch mutagenesis in order to introduce a stop codon within the
frame of the Pol protein. This stop codon insertion terminates Gag-Pol
synthesis in aa 13 of PR. As a result, this mutation does not allow the
synthesis of full-length Gag-Pol and the expression of a functional PR.
HXB2-BH10 was used for the construction of both the G and the GP
clones.
The DNA regions containing mutations within the primary cleavage site
(p2/NC) or in primary and late cleavage sites (p2/NC and CA/p2) were
removed from CA2 or CA6 mutants and cloned into the G and GP plasmids
via SpeI and ApaI restriction enzyme sites.
Virus production.
The production of WT and mutant HIV-1
viral particles was achieved by transfection of 10 µg of proviral DNA
of each plasmid into 293T cells using a calcium phosphate method as
previously described (29).
The production of HIV-1 particles containing mutations in the cleavage
sites of Gag or Gag-Pol was achieved by cotransfection of either intact
G or GP DNA plasmids with the mutated counterparts maintaining the 20:1
GagUAA/GP ratio (10 µg of G to 0.5 µg of GP)
found in natural infections. Cotransection of intact G and GP vectors
resulted in the 20:1 Gag/Gag-Pol protein expression ratio in the
virus-producing cells. An enhanced green fluorescent protein
(EGFP; Clontech) reporter plasmid (2 µg) was added to the DNA mixture
to determine the transfection efficiency.
Supernatants were collected 36 h posttransfection and centrifuged
for 30 min at 4°C and 3,000 rpm (Beckman) to remove cellular debris.
The clarified supernatants were either frozen at
70°C or used
immediately for further analysis. Cells were washed twice with either
phosphate-buffered saline (PBS) or 1× Tris-buffered saline (TBS)
buffer (50 mM Tris, pH 7.4; 150 mM NaCl), followed by protein
extraction using lysis buffer containing 1× TBS, 10 µl of Nonidet
P-40/ml, 20 mM phenylmethylsulfonyl fluoride, 1 µM pepstatin, and 1 µM leupeptin. Cell lysates were collected and stored at
20°C for
later use.
Intracellular viral protein analysis.
Cell lysates were
rapidly frozen and thawed three times to weaken the cellular membrane.
Cell debris was subsequently removed by centrifugation for 30 min at
4°C at 3,000 rpm (Beckman). The transfection efficiency of the
samples was determined by measuring the level of EGFP from the reporter
plasmid using a Bio Imaging Analyzer (Fuji Photo Film Co.).
Intracellular viral protein from each sample normalized for equivalent
levels of EGFP was mixed with 3 µl of sample buffer (100 mM Tris, pH
6.8; 3% sodium dodecyl sulfate [SDS]; 33% glycerol; 0.03%
bromophenol blue), denatured for 10 min at 95°C, and resolved by
SDS-10% polyacrylamide gel electrophoresis (PAGE). Resolved proteins
were transferred to a nitrocellulose membrane (Amersham) for Western
blot analysis. The membrane was blocked for 2 h in 3% casein
dissolved in 2× TBS containing 0.3% Tween 20 (TBST) and probed
overnight with pooled HIV-1-seropositive patient sera or anti-p24/CA
monoclonal antibody (MAb) (NEN). After three washes with 1× TBST
buffer the membrane was incubated with anti-human or anti-mouse
horseradish peroxidase-conjugated secondary antibody (Dako) for 2 h at room temperature. An enhanced chemiluminescence (ECL) technique
was used for detection of HIV-1 proteins present in the intracellular lysates (Amersham). Results were visualized by autoradiography.
Virion purification and protein analysis.
Clarified
supernatants from transfected cells were purified and concentrated by
ultracentrifugation through a 20% sucrose cushion in TE buffer (10 mM
Tris, 1 mM EDTA; pH 8.0) by using a Beckman L-90 ultracentrifuge (SW41
rotor) at 35,000 rpm for 1 h at 4°C. Pellets were resuspended in
50 µl of TBS lysis buffer.
Analysis of virion protein profile.
Equal amounts of virion
protein normalized by dot blotting (46) from each sample
were mixed with 3 µl of sample buffer containing 5 mM
-mercaptoethanol and heated for 10 min at 95°C. Virion proteins for analysis of the HIV-1 protein pattern and detection of p24-CA were
then resolved by SDS-10% PAGE as described above. The resolved virion
protein samples were transferred onto nitrocellulose membranes for
Western blot analysis as described above. For the detection of p7-NC
protein, normalized and denatured virion proteins were resolved in a
16.5% Tricine gel (Bio-Rad) under electrophoresis conditions with a
Tris-Tricine buffer. Resolved proteins were transferred to a
polyvinylidene difluoride membrane. An ECL technique was used for the
detection of mature and intermediate NC proteins present in the virions
(Amersham). Results were visualized by autoradiography.
Analysis of virion RNA dimerization.
Virion pellets were
resuspended in 500 µl of dimeric RNA lysis buffer (10 mM Tris [pH
7.5], 1 mM EDTA, 1% SDS, 50 mM NaCl, and 10 U of proteinase K), lysed
for 30 min at room temperature, phenol-chloroform extracted, and
isolated for melting-curve analysis as previously described (18,
19).
Similar amounts of genomic RNA were used to analyze the stability of
the virion RNA dimer in each preparation by heating the samples at the
indicated temperatures for a period of 10 min, followed by a quick
chill in ice. Heat-denatured dimeric and monomeric RNAs were separated
by electrophoresis in a 1% native agarose gel in 0.5×
Tris-borate-EDTA buffer and transferred overnight onto a nitrocellulose
(Hybond N) membrane (Amersham). The membrane containing the RNA samples
was air dried for 2 h at room temperature and exposed to UV light
for 90 s to allow cross-linking to occur. The membrane was blocked
for 1 h at 42°C with 10 ml of hybridization buffer
(30). Dimeric and monomeric RNAs were incubated overnight with a 32P-labeled riboprobe, which is
complementary to the 5' end of the HIV-1 genomic RNA sequences, as
previously described (46). The riboprobe was synthesized
by linearizing the pGEM7z HIV-1 plasmid with BamHI, followed
by T7 RNA polymerase-TP (NEN). After the probing, the membrane was
washed once for 30 min with 1× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS buffer and twice for 30 min with 0.2×
SSC-0.1% SDS buffer. The results were visualized by autoradiography.
Migration of WT RNA as well as RNA derived from the cotransfection of
the intact G and GP plasmids served as controls to determine the effect
of cleavage site mutations on RNA dimerization.
TSEM.
Transfected 293T cells were harvested at appropriate
times posttransfection and processed for thin-section electron
microscopy (TSEM) as described previously (32). Briefly,
cells were washed in cacodylate (CAC) buffer (pH 7.2) and pelleted by
centrifugation at 500 × g for 5 min. The cell pellet
was then fixed in 2% glutaraldehyde-CAC buffer for 1 h at 4°C.
After several washes in CAC buffer, the pellet underwent secondary
fixation in 1% osmium tetroxide-CAC buffer for 1 h at 4°C.
Pellets were rinsed in distilled water, dehydrated in graded ethanol,
cleared in propylene oxide, and embedded in Spurr resin (Ladd Research,
Inc., Williston, Vt.). Ultrathin sections with silver and gold
interference color were mounted on uncoated 200-mesh copper grids and
stained with uranyl acetate and lead citrate. The sections were then
examined by using a CM12 electron microscope (Philips, Eindhoven, The Netherlands).
 |
RESULTS |
Mutations in the Gag and Gag-Pol cleavage sites of HIV-1 inhibit
proteolysis by PR.
Cells transfected with either the WT, NL4.3, or
the cleavage site mutants of this full-length molecular clone had
protein profiles similar to those previously described
(51; S. Pettit and R. Swanstrom, unpublished data). Virion
protein profiles of cleavage site mutants probed with anti-p24 MAb were
in agreement with previous reports (51; Pettit and
Swanstrom, unpublished) (Fig. 2).
Briefly, the WT (NL4.3) and the p1/p6 mutant expressed similar levels
of CA-p24 (Fig. 2, panel i/A, lanes 1 and 2). Mutant MA/CA yielded an
MA-CA intermediate product with a relative molecular mass of 39 kDa
(Fig. 2, panel i/A, lane 3) as a result of a point mutation that
hinders the release of the N terminus of the capsid protein from
matrix. As previously observed (51; Pettit and Swanstrom,
unpublished), mutants CA/p2 and CA5 yielded similar levels of a CA-p2
intermediate (CA extended by 14 aa) and no mature CA-p24 (Fig. 2, panel
i/A, lane 4, and panel i/B, lane 2). The CA2 mutant expressed less
CA-p24 and a CA-NC protein complex (Fig. 2, panel i/B, lane 1) due to
inefficient processing of the N terminus of NC. This resulted in the
formation of a p33 CA-p2-NC processing intermediate. The presence of
CA-p24 suggests that the p2/NC mutation hindered but did not block the
release of an N-terminally extended NC protein from the CA-p2-NC (p25)
intermediate. As expected, no CA-p24 protein was detected for CA6 (Fig.
2, panel i/B, lane 3) due to point mutations in the primary site
(p2/NC), the tertiary site (CA/p2), and a further cryptic cleavage
site. These mutations completely blocked the release of the NC from the
CA-p2 protein complex, resulting in virions containing predominantly a
CA-p2-NC processing intermediate.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Impact of mutations within the primary, secondary, and
late-proteolytic processing cleavage sites of HIV-1 on the protein
composition of purified virions. Viral proteins were semiquantified by
Western blot analysis. Purified virions were resolved by using 10%
Tris-glycine SDS-PAGE (i) and by 16.5% Tris-Tricine SDS-PAGE (ii).
Resolved proteins were probed with anti-p24 MAb or anti-p7 polyclonal
antibody with specific activity to NC protein, as described in
Materials and Methods.
|
|
WT, p1/p6, MA/CA, CA/p2, and CA5 mutants expressed similar levels of
p7-NC in the virions (Fig. 2iiA, lanes 1 to 4, and iiB, lane 2). The
mutation in the p2/NC cleavage site resulted in the release of a p9
(NC-p2) intermediate and no mature p7-NC, whereas combined mutations in
the p2/NC and CA/p2 cleavage sites blocked processing of p2 from NC and
CA from p2, giving rise to a p33 protein complex (Fig. 2iiB, lanes 1 and 3, respectively). The p33 protein complex was also observed in the
p2/NC mutant virions, supporting the results obtained from the
detection of CA-p24 described above.
A primary cleavage site mutation in Gag/Gag-Pol leads to reduced
stability of the HIV-1 RNA dimers.
Dimeric RNA was observed in all
mutant viruses, regardless of the nature of the mutation introduced in
the full-length HIV-1 genome (Fig. 3).
However, the stability of the dimeric RNA was markedly reduced when
mutations were introduced in the primary cleavage site alone (CA2, Fig.
3B) or in both primary and tertiary cleavage sites (CA6, Fig. 3B). In
these preparations, virion RNA dimers began to dissociate into monomers
at temperatures as low as 42°C; in fact, almost all of the virion
RNAs were detected as monomers when the samples were heated to 48°C.
In contrast, HIV-1 mutants containing mutations in secondary (MA/CA and
p1/p6, Fig. 3A) or tertiary proteolytic cleavage sites (CA/p2, Fig. 3A, and CA5, Fig. 3B) exhibited the same RNA dimer stability as that of the
WT counterpart (NL 4.3, Fig. 3A); in these preparations, virion RNA
dimers could still be detected at higher dissociation temperatures (48 to 50°C).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of mutations within the primary, secondary, and
late cleavage sites on virion RNA dimerization. The impact of mutations
within proteolytic processing cleavage sites on genomic RNA
dimerization was determined by using melting-curve and electrophoretic
analysis of WT and mutant dimers. Virion RNA was resuspended in RNA
dimerization buffer and heat denatured for 10 min at the indicated
temperatures. Dimers and monomers were electrophoresed in a 1% native
agarose gel and probed with an HIV-1 riboprobe, as described in
Materials and Methods. (A) RNA dimerization analysis of genomic RNA
isolated from WT HIV-1 (NL4.3), CA/p2, MA/CA, and p1/p6 mutant virions.
(B) RNA dimerization analysis of genomic RNA isolated from CA2, CA5,
and CA6 mutant virions.
|
|
Cleavage site mutations in Gag affect the HIV-1 virion protein
profiles much more than the same mutations in Gag-Pol.
We have
shown in Fig. 3 that a single (p2/NC) or a triple mutation (p2/NC,
CA/p2, and in a cryptic site) block full processing of CA and NC
proteins and destabilize virion RNA dimers. The relative contribution
to this effect of the respective cleavage sites in Gag versus the
corresponding sites in Gag-Pol is unknown. To answer this question, we
have introduced either the p2/NC cleavage site mutation (CA2) or the
combined p2/NC, CA/p2, and a cryptic site mutation (CA6) into either G
or the GP expression vector (Fig. 4). The
resultant DNA constructs were designated GCA2,
GCA6, GPCA2, and
GPCA6, respectively. The Gag (G) expression
construct was then transfected with GPCA2 alone
or in combination with GPCA6 mutant, while the
Gag-Pol (GP) expression construct was transfected with
GCA2 alone or in combination with
GCA6.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic representation of WT control and G and GP
plasmid DNA used in cotransfections for the production of viral
particles containing mutations in cleavage sites in either Gag or
Gag-Pol. WT HXB2-BH10 was used for the construction of both the
GagUAA (G) and the GP clones. The G plasmid was constructed
by using PCR stitch mutagenesis in order to introduce a stop codon
within the frame of the Pol protein. The Gag-Pol expression plasmid
(GP) has been previously described (37). The frameshift
mutation introduced here allows continuous expression of Gag-Pol and
bypasses the Gag termination codon. The DNA regions containing
mutations within the primary cleavage site (p2/NC) or in primary and
tertiary cleavage sites (p2/NC and CA/p2) were removed from CA2 or CA6
mutants and cloned into the G and GP plasmids via SpeI
and ApaI restriction enzyme sites, respectively. The
resultant mutants were termed GCA2, GCA6,
GPCA2, and GPCA6 (see also Table 2). The
G plasmid was then cotransfected with either GPCA2 alone or
in combination with GPCA6 while the GP plasmid was
cotransfected with either GCA2 alone or in combination with
GCA6 in 293T cells.
|
|
Since cotransfection of the WT Gag and WT Gag-Pol expression vectors
(G/GP) produced viral particles with the same intracellular viral
protein and virion protein profiles as WT virus (Fig.
5, lanes b), G/GP viruses were used as
controls in all of the subsequent cotransfection studies (Fig. 5, lanes
1). Intracellular viral proteins and virion proteins derived from cells
cotransfected with GCA2/GP constructs yielded
levels of CA-p24 and CA-NC that were similar to those observed for the
CA2 mutation in a proviral clone (Fig. 5, lanes 4), while
G/GPCA2 intracellular and virion proteins yielded
undetectable levels of CA-NC (Fig. 5, lanes 2). Accordingly, almost
exclusively, CA-NC was observed upon cotransfection of
GCA6 /GP (Fig. 5, lanes 5), while significantly
lower levels of intracellular viral protein and virion CA-NC protein
complex were yielded upon cotransfection with
G/GPCA2 or G/GPCA6 (Fig. 5,
lanes 2 and lanes 3, respectively).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of a primary or combined primary and late
cleavage site mutations within Gag or Gag-Pol on intracellular viral
proteins and virion protein profiles of HIV-1. Intracellular viral
proteins were standardized by EGFP, and total virion protein levels
were standardized by dot blot analysis (data not shown). Cotransfected
cell lysates (A) and purified virions (see Materials and Methods) (B)
were resolved by SDS-10% PAGE. Resolved proteins were probed using
sera from HIV-1-infected individuals, as described in Materials and
Methods. Lanes 1, show G/GP cellular viral proteins and virion protein
profiles, respectively. Lanes 2 and lanes 3 show cellular viral
proteins and virion protein profiles of mutant viruses containing a
primary CA2 (p2/NC) or a combined primary and late cleavage site
mutation CA6 (p2/NC, CA/p2, and a cryptic site mutation) in Gag-Pol,
respectively. Lanes 4 and lanes 5 show cellular viral proteins and
virion protein profiles of mutant viruses containing a primary CA2
(p2/NC) or a combined primary and late cleavage site mutation CA6
(p2/NC and CA/p2) in Gag, respectively. Lanes a and lanes b show mock-
and WT-transfected controls. The amounts of WT HIV-1 intracellular and
virion proteins were independent of the other proteins tested and were
used in these analysis only to compare HIV-1 protein patterns probed by
HIV-1 sera.
|
|
The primary cleavage site in Gag is more important for RNA
dimerization than the corresponding site in Gag-Pol.
Genomic RNA
isolated from viral particles derived from cotransfection of plasmids G
and GP was dimeric and exhibited the same stability as virion RNA
dimers isolated from WT NL4.3 virus (compare Fig.
6 and Fig. 3A, respectively). Genomic RNA
isolated from viral particles containing the primary cleavage site
mutation in Gag (GCA2/GP) started to dissociate
into monomers at room temperature, while dimeric RNA from viral
particles containing the corresponding mutation in Gag-Pol
(G/GPCA2) was as heat stable as WT G/GP RNA dimers, with a dissociation temperature of 45 to 48°C (Fig. 6A and B,
respectively). The introduction of the combined mutations in Gag
(GCA6/GP) further decreased dimer stability with
more than 50% of the RNA dimers dissociating into monomers at room
temperature (Fig. 6A), while the corresponding mutations in Gag-Pol
(G/GPCA6) caused a negligible decrease in the
dimer stability of the RNA (Fig. 6B). These results show that the
primary cleavage site in Gag-Pol plays a less important role in dimer
RNA stability than the corresponding site in Gag.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of cleavage site mutations in either Gag or
Gag-Pol on virion RNA dimerization. The impact of mutations in the
proteolytic processing cleavage sites within Gag or Gag-Pol on genomic
RNA dimerization was examined by melting curve and electrophoretic
analysis of WT and mutant dimers. Dimers and monomers were
electrophoresed in 1% native agarose gel and probed with an HIV-1
riboprobe, as described in Materials and Methods. (A) RNA dimerization
analysis of genomic RNA isolated from WT (G/GP) and mutant
G/GPCA2 or G/GPCA6 virions. (B) RNA
dimerization analysis of genomic RNA isolated from GCA2/GP
and GCA6/GP mutant virions.
|
|
Mutations in the primary cleavage site of Gag (but not in Gag-Pol)
inhibit core formation.
Immature (Fig.
7A) and mature (Fig. 7B) forms of virus
detected on or near the surface of the cells transfected with G/GP DNA
constructs were similar in morphology to their WT HIV-1 counterpart. The G/GP immature virions were observed as round or ovoid enveloped particles containing an inner ring and having a hollow appearance (Fig.
7A). In contrast, the mature G/GP virions appeared as round or ovoid
spherical enveloped particles containing a mature electron-dense core,
which appeared cone shaped or round depending on the angle of
sectioning (Fig. 7B). In cells cotransfected with
GCA2/GP (Fig. 7C and D) and
GCA6/GP (Fig. 7E and F) DNA constructs, only
immature forms of the virus were detected; at times, an internal
structure similar to that reported by Hockley et al. (27)
was observed within these immature virions (Fig. 7D and F). In
preparations that were derived from cells cotransfected with
G/GPCA2 and G/GPCA6 constructs, both immature (Fig. 7G and I) and mature (Fig. 7H and J)
virions were detected; the ratios of immature to mature virions in
these preparations were similar to those derived from the G/GP
preparation (data not shown). Measurements of virus particles (Table
2) showed no significant differences
between mutant and WT virions either in the mature or in the immature
form.

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 7.
Electron microscopic analysis of the mutant viral
particles. 293T cells were cotransfected with G/GP (A and B),
GCA2/GP (C and D), GCA6/GP (E and F),
GCA2/GP (C and D), and GCA6/GP (E and F). DNA
constructs were harvested at 36 h posttransfection and processed
for TSEM as described in Materials and Methods. Both immature (A, G,
and I) and mature (B, H, and J) forms of the virus were detected on or
near the surface of the cells transfected with G/GP (control),
G/GPCA2, or G/GPCA6. Only immature virions were
observed within the GCA2/GP (C and D) and
GCA6/GP (E and F) preparations. (D and F) At times, an
internal structure (arrow) within the inner ring of the immature virion
was seen. Two diameters were measured for each viral particle: the
longest and shortest diameters, roughly at right angles; the average of
the two values was then taken as the diameter of the viral particle.
Bars, 100 nm.
|
|
 |
DISCUSSION |
This study provides direct evidence that the sequential processing
of Gag and Gag-Pol proteins by viral protease regulates genomic RNA
maturation (i.e., RNA dimerization and stability). Virion RNA dimer
maturation was dependent on the proteolysis of the primary cleavage
site of Gag but independent of the processing of the secondary and
tertiary cleavage sites. Furthermore, the cleavage of the p2/NC site in
Gag but not Gag-Pol was critical for the formation of stable RNA dimers
and condensation of the virion core. Our study supports and extends
previous reports (1, 2, 14, 16, 17, 40) showing that
genomic RNA dimer formation is under the control of Gag protein and
that formation of N terminally cleaved NC is required for the
generation of stable RNA dimers.
The cleavage of the p2/NC site in HIV-1 is critical for virion RNA
dimer stability.
Previous studies have suggested that Gag/Gag-Pol
PR processing may influence RNA dimerization. Fu and coworkers
(18, 19) have shown that PR activity is required for RNA
dimer stability. Our study shows that mutations of the primary (p2/NC)
Gag/Gag-Pol cleavage site dramatically decrease the stability of virion
RNA dimers. In contrast, RNA dimer stability remains unaffected by mutations in the secondary and tertiary cleavage sites. Our findings suggest that the p2-NC intermediate found in virions as a result of
altered processing in the p2/NC site is unable to substitute for fully
processed NC in the formation of stable virion RNA dimers. Therefore,
the release of the NC protein from p2, thus freeing the N terminus of
the NC protein, is essential for stable genomic RNA dimer formation.
Mature NCp7 has been reported to convert unstable RNA dimers into
stable dimers in a cell free system by interacting with a "kissing
loop complex," suggesting that NCp7 is an important contributor to
RNA dimer formation (16, 17, 40). A similar observation
has also been made for Moloney murine leukemia virus (MoMLV)-derived
genomic RNA in vitro (8).
We speculate that the interaction between genomic RNA and an NC
intermediate (NC-p1-p6 or p15) is sufficient for the formation of the
dimeric RNA complex. However, the data suggest that the free N terminus
of NC in the context of p15 is critical for the stability of these
dimers in vivo and is in agreement with earlier reports from
studies in a cell-free system in HIV-1 (2), as well as in
MoMLV and Harvey murine sarcoma virus (17, 38). In
another study, Wiegers et al. (51) have shown that a
mutation in the p2/NC site results in the production of viral particles with immature cores. In addition, our data suggest that the release of
the NC from p2 leads to RNA maturation. Formation of the RNP complex
and condensation of the core may follow this step. Taken together,
these results point to a specific role of NC for stable RNA dimer
formation and condensation.
The proteolytic processing of the p2/NC cleavage site in Gag (but
not Gag-Pol) is essential for RNA dimer stability and virion core
formation.
We introduced the p2/NC mutation alone or in
combination with the CA/p2 mutation into Gag or Gag-Pol in order to
determine the contribution of these cleavage sites in Gag versus
Gag-Pol in RNA dimerization and virion core formation. Our data showed a significant decrease in CA-NC processing, a dramatic effect in RNA
dimer stability and immature core formation when these mutations were
introduced only in Gag. Gag-Pol protein is synthesized as a result of a
1 frameshifting event resulting in a 20:1 production ratio of Gag to
Gag-Pol in the virus producing cell (28). Therefore, the
ratio of CA and NC derived from Gag protein to CA and NC derived from
Gag-Pol protein at the assembly site of new virions should correspond
with that of the WT Gag/Gag-Pol ratio (i.e., 20:1). In agreement with
this ratio, our data show that the cleavage of the p2/NC site in Gag is
essential for RNA dimer stability and virion core formation and further
suggest that Gag-Pol proteins contribute only modestly to RNA dimer stability.
A free N terminus of NC is important for HIV-1 core formation.
NC plays diverse roles in HIV-1 replication (13). The NC
domain in the Gag polyprotein facilitates RNA packaging and is involved
in reverse transcription of the viral genome and possibly at later
stages of viral entry (45). A later report has confirmed that mutations in the basic residues of the N terminal of NC lead to
production of viral particles containing defective cores
(6). Assembly studies in a cell free system have
demonstrated that the MA-CA-NC complex gives rise to spherical
particles and that the formation of tubular cores (in Escherichia
coli) and conical cores requires only the CA-NC portion of this
protein in the presence of RNA (9, 10, 21, 24, 25). Our
results clearly show that in HIV-1, hindering the processing of the N
terminus of NC from CA protein prevented virus maturation. The data
demonstrate a strong association between stable RNA dimer formation and
core maturation, as well as the importance of the N terminus of NC in
both events. The presence of the RNA dimers within these immature viral
particles, however, suggests that virion genomic RNA initially dimerizes as a thermally less stable structure. RNA-NC structural studies have shown that the free amino terminus of NC resides in the
groove of a stem-loop RNA structure (15) which implies that this aspect of NC-RNA interaction is likely to be an important determinant for virion RNA packaging. Fuller et al. (20)
have suggested that RNA may function as a scaffold in the formation of
the immature spherical shell. In this case, cleavage of NC leading to
the release of the RNP complex may be required for the morphologic
rearrangement as it permits removal of the NC-RNA scaffold from the
condensing core structure. Concomitantly, freeing the N terminus of NC
appears to be necessary and may be sufficient for the formation of
stable RNA dimers, which can serve as a nucleating event in core maturation.
In summary, our data suggest that correct N-terminal processing of NC
during viral assembly is a requirement for HIV-1 core formation and
high stability of RNA dimers. Once NC is separated from p2, precise
levels of mature CA and NC proteins are generated to form the conical
capsid shell and facilitate the condensation of the electron-dense RNP
core. The study implies that processing of Gag polyprotein is critical
for RNA dimerization.
 |
ACKNOWLEDGMENTS |
We thank Jean-Luc Darlix for useful discussions and John Mills
for comments and review of the manuscript.
Miranda Shehu-Xhilaga is a recipient of an NHMRC Dora Lush Ph.D.
scholarship. Suzanne M. Crowe is supported by a grant from the
Australian National Council of HIV/AIDS and Related Diseases, the
Australian National Centre in HIV Virology Research, and the MBC
Research Fund. Johnson Mak is a recipient of an NHMRC Peter Doherty
postdoctoral fellowship. This work was supported in part by NIH grant
RO1-AI25321 to Ronald Swanstrom.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: AIDS
Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical
Research, Fairfield, Victoria, Australia 3078. Phone: 61-3-9282-2217. Fax: 61-3-9482-6152. E-mail: mak{at}burnet.edu.au.
 |
REFERENCES |
| 1.
|
Aldovini, A., and R. A. Young.
1990.
Mutations of RNA and protein sequences involved in human immunodefieciency virus type 1 packaging result in production of noninfectious virus.
J. Virol.
64:1920-1926[Abstract/Free Full Text].
|
| 2.
|
Barat, C.,
V. Lullien,
O. Schatz,
G. Keith, and J. L. Darlix.
1989.
HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.
EMBO J.
8:3279-3285[Medline].
|
| 3.
|
Berkhout, B.
1996.
Structure and function of the human immunodeficiency virus leader RNA.
Prog. Nucleic Acids Res. Mol. Biol.
54:1-34[Medline].
|
| 4.
|
Berkowitz, R. D., and S. P. Goff.
1994.
Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein.
Virology
202:233-246[CrossRef][Medline].
|
| 5.
|
Berkowitz, R. D.,
J. Luban, and S. P. Goff.
1993.
Specific binding of human immunodeficiency virus type 1 Gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
J. Virol.
67:7190-7200[Abstract/Free Full Text].
|
| 6.
|
Berthoux, L.,
C. Pechoux,
M. Ottoman,
G. Morel, and J. L. Darlix.
1997.
Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
J. Virol.
71:6225-6981[Abstract].
|
| 7.
|
Billich, S.,
M. T. Knoop,
J. Hansen,
P. Strop,
J. Sedlacek,
R. Mertz, and K. Moelling.
1988.
Synthetic peptides as substrates and inhibitors of human immunodeficiency virus-1 protease.
J. Biol. Chem.
263:17905-17908[Abstract/Free Full Text].
|
| 8.
|
Bonnet-Mathoniere, B.,
P. Girard,
D. Muriaux, and J. Paoletti.
1996.
Nucleocapsid protein 10 activates dimerization of the RNA of Moloney murine leukemia virus in vitro.
Biochemistry
238:129-135.
|
| 9.
|
Campbell, S., and A. Rein.
1999.
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
J. Virol.
73:2270-2279[Abstract/Free Full Text].
|
| 10.
|
Campbell, S., and V. M. Vogt.
1995.
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
J. Virol.
69:6487-6497[Abstract].
|
| 11.
|
Clever, J.,
C. Sassetti, and T. G. Parslow.
1995.
RNA secondary structure and binding site for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
J. Virol.
69:2101-2109[Abstract].
|
| 12.
|
Craven, R. C., and L. J. Parent.
1996.
Dynamic interactions of the Gag polyprotein.
Curr. Top. Microbiol. Immunol.
214:65-94[Medline].
|
| 13.
|
Darlix, J.-L.,
M. Lapadat-Tapolsky,
H. de Rocquigny, and B. P. Roques.
1995.
First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses.
J. Mol. Biol.
254:523-537[CrossRef][Medline].
|
| 14.
|
Darlix, J. L.,
C. Gabus,
M. T. Nugeyre,
F. Clavel, and F. Barre-Sinoussi.
1990.
cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.
J. Mol. Biol.
216:689-699[CrossRef][Medline].
|
| 15.
|
De Guzman, R. N.,
Z. R. Wu,
C. C. Stalling,
L. Pappalardo,
P. N. Borer, and M. F. Summers.
1998.
Structure of the HIV-1 nucleocapsid protein bound to the SL3 -RNA recognition element.
Science
279:384-388[Abstract/Free Full Text].
|
| 16.
|
Feng, Y.-X.,
S. Campbell,
D. Harvin,
B. Ehresmann,
C. Ehresmann, and A. Rein.
1999.
The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.
J. Virol.
73:4251-4256[Abstract/Free Full Text].
|
| 17.
|
Feng, Y.-X.,
T. D. Copeland,
L. E. Henderson,
R. J. Gorelick,
W. J. Bosche,
J. G. Levin, and A. Rein.
1996.
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.
Proc. Natl. Acad. Sci. USA
93:7577-7581[Abstract/Free Full Text].
|
| 18.
|
Fu, W.,
R. J. Gorelick, and A. Rein.
1994.
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
J. Virol.
68:5013-5018[Abstract/Free Full Text].
|
| 19.
|
Fu, W., and A. Rein.
1993.
Maturation of dimeric viral RNA of Moloney murine leukemia virus.
J. Virol.
67:5443-5449[Abstract/Free Full Text].
|
| 20.
|
Fuller, S. D.,
T. Wilk,
B. E. Gowen,
H.-G. Kräusslich, and V. M. Vogt.
1997.
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.
Curr. Biol.
7:729-738[CrossRef][Medline].
|
| 21.
|
Ganser, B. K.,
S. Li,
V. Y. Klishko,
J. T. Finch, and W. I. Sundquist.
1999.
Assembly and analysis of conocal models for HIV-1 core.
Science
283:80-83[Abstract/Free Full Text].
|
| 22.
|
Gorelick, R. J.,
D. J. Chabot,
A. Rein,
L. E. Henderson, and L. O. Arthur.
1993.
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
J. Virol.
67:4027-4036[Abstract/Free Full Text].
|
| 23.
|
Gorelick, R. J.,
J. S. M. Nigida,
J. J. W. Bess,
L. O. Arthur,
L. E. Henderson, and A. Rein.
1990.
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.
J. Virol.
64:3207-3211[Abstract/Free Full Text].
|
| 24.
|
Gross, I.,
H. Hohenberg,
C. Huckhagel, and H.-G. Kräusslich.
1998.
N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
J. Virol.
72:4798-4810[Abstract/Free Full Text].
|
| 25.
|
Gross, I.,
H. Hohenberg,
T. Wilk,
K. Wiegers,
M. Grattinger,
B. Muller,
S. Fuller, and H. G. Krausslich.
2000.
A conformational switch controlling HIV-1 morphogenesis.
EMBO J.
19:103-113[CrossRef][Medline].
|
| 26.
|
Henderson, L. E.,
M. A. Bowers,
R. Sowder,
S. A. Serabyn,
D. G. Johnson,
J. J. Bess,
L. O. Arthur,
D. K. Bryant, and C. Fenselau.
1992.
Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processing and complete amino acid sequences.
J. Virol.
66:1856-1865[Abstract/Free Full Text].
|
| 27.
|
Hockley, D. J.,
R. D. Wood,
J. P. Jacobs, and A. J. Garrett.
1988.
Electron microscopy of human immunodeficiency virus.
J. Gen. Virol.
69:2455-2469[Abstract/Free Full Text].
|
| 28.
|
Jacks, T.,
M. D. Power,
F. R. Masiarz,
P. A. Luciw,
P. J. Barr, and H. E. Varmus.
1988.
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.
Nature
331:280-283[CrossRef][Medline].
|
| 29.
|
Jiang, M.,
J. Mak,
A. Ladha,
E. Cohen,
M. Klein,
B. Rovinski, and L. Kleiman.
1993.
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.
J. Virol.
67:3246-3253[Abstract/Free Full Text].
|
| 30.
|
Kaplan, A. H.,
M. Manchester, and R. Swanstrom.
1994.
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.
J. Virol.
68:6782-6786[Abstract/Free Full Text].
|
| 31.
|
Kräusslich, H. G. (ed.).
1996.
Morphogenesis and maturation of retroviruses, vol. 214.
Springer, Heidelberg, Germany.
|
| 32.
|
Lee, J. Y.,
J. A. Marshall, and D. S. Bowden.
1992.
Replication complexes associated with the morphogenesis of rubella virus.
Arch. Virol.
122:95-106[CrossRef][Medline].
|
| 33.
|
Liang, C.,
L. Rong,
E. Cherry,
L. Kleiman,
M. Laughrea, and M. A. Wainberg.
1999.
Deletion mutagenesis within the dimerization initation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.
J. Virol.
73:6147-6151[Abstract/Free Full Text].
|
| 34.
|
Liang, C.,
L. Rong,
M. Laughrea,
L. Kleiman, and M. A. Wainberg.
1998.
Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initation site can restore viral replication.
J. Virol.
72:6629-6636[Abstract/Free Full Text].
|
| 35.
|
Lindhofer, H.,
K. von der Helm, and H. Nitschko.
1995.
In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T lymphocytes.
Virology
214:624-627[CrossRef][Medline].
|
| 36.
|
Luban, J., and S. P. Goff.
1994.
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
J. Virol.
68:3784-3793[Abstract/Free Full Text].
|
| 37.
|
Mak, J.,
A. Khorchid,
Q. Cao,
Y. Huang,
I. Lowy,
V. R. Prasad,
M. A. Parniak,
M. A. Wainberg, and L. Kleiman.
1997.
Effects of mutations in Pr160gag-pol upon tRNALys3 and Pr160gag-pol incorporation into HIV-1.
J. Mol. Biol.
265:419-431[CrossRef][Medline].
|
| 38.
|
Méric, C., and S. P. Goff.
1989.
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.
J. Virol.
63:1558-1568[Abstract/Free Full Text].
|
| 39.
|
Méric, C., and P. F. Spahr.
1986.
Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging.
J. Virol.
60:450-459[Abstract/Free Full Text].
|
| 40.
|
Muriaux, D.,
H. De Rocquigny,
B. Roques, and J. Paoletti.
1996.
NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer.
J. Biol. Chem.
271:33686-33692[Abstract/Free Full Text].
|
| 41.
|
Oroszlan, S., and T. B. Luftig.
1990.
Retroviral proteinase.
Curr. Top. Microbiol. Immunol.
157:153-185[Medline].
|
| 42.
|
Pettit, S. C.,
M. D. Moody,
R. S. Wehbie,
A. H. Kaplan,
P. V. Nantermet,
C. A. Klein, and R. Swanstrom.
1994.
The P2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
J. Virol.
68:8017-8027[Abstract/Free Full Text].
|
| 43.
|
Pettit, S. C.,
N. Sheng,
R. Tritch,
S. Erickson-Vitanen, and R. Swanstrom.
1998.
The regulation of sequential processing of HIV-1 Gag by the viral protease.
Adv. Exp. Med. Biol.
436:15-25[Medline].
|
| 44.
|
Pettit, S. C.,
J. Simsic,
D. Loeb,
L. Everitt,
C. A. Hutchison III, and R. Swanstrom.
1991.
Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the p1 amino acids.
J. Biol. Chem.
266:14539-14547[Abstract/Free Full Text].
|
| 45.
|
Poon, D. T. K.,
J. Wu, and A. Aldovini.
1996.
Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
J. Virol.
70:6607-6616[Abstract/Free Full Text].
|
| 46.
|
Shehu-Xhilaga, M.,
S. M. Crowe, and J. Mak.
2001.
Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
J. Virol.
75:1834-1841[Abstract/Free Full Text].
|
| 47.
|
Sheng, N., and S. Erickson-Viitanen.
1994.
Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.
J. Virol.
68:6207-6214[Abstract/Free Full Text].
|
| 48.
|
Swanstrom, R., and J. W. Wills.
1997.
Retroviral gene expression. II. Synthesis, processing, and assembly of viral proteins, p. 263-334.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 49.
|
Terwilliger, E.,
J. G. Sodroski,
C. A. Rosen, and W. A. Haseltine.
1986.
Effects of mutations within the 3' open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.
J. Virol.
60:754-760[Abstract/Free Full Text].
|
| 50.
|
Vogt, V. M.
1996.
Proteolytic processing and particle maturation.
Curr. Top. Microbiol. Immunol.
214:95-132[Medline].
|
| 51.
|
Wiegers, K.,
G. Rutter,
H. Kottler,
U. Tessmer,
H. Hohenberg, and H.-G. Kräusslich.
1998.
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
J. Virol.
72:2846-2854[Abstract/Free Full Text].
|
Journal of Virology, October 2001, p. 9156-9164, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9156-9164.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Henriet, S., Sinck, L., Bec, G., Gorelick, R. J., Marquet, R., Paillart, J.-C.
(2007). Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res
35: 5141-5153
[Abstract]
[Full Text]
-
Sun, X., Zhang, Q., Al-Hashimi, H. M.
(2007). Resolving fast and slow motions in the internal loop containing stem-loop 1 of HIV-1 that are modulated by Mg2+ binding: role in the kissing-duplex structural transition. Nucleic Acids Res
35: 1698-1713
[Abstract]
[Full Text]
-
Fu, W., Dang, Q., Nagashima, K., Freed, E. O., Pathak, V. K., Hu, W.-S.
(2006). Effects of Gag Mutation and Processing on Retroviral Dimeric RNA Maturation. J. Virol.
80: 1242-1249
[Abstract]
[Full Text]
-
Cruceanu, M., Urbaneja, M. A., Hixson, C. V., Johnson, D. G., Datta, S. A., Fivash, M. J., Stephen, A. G., Fisher, R. J., Gorelick, R. J., Casas-Finet, J. R., Rein, A., Rouzina, I., Williams, M. C.
(2006). Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res
34: 593-605
[Abstract]
[Full Text]
-
Buxton, P., Tachedjian, G., Mak, J.
(2005). Analysis of the Contribution of Reverse Transcriptase and Integrase Proteins to Retroviral RNA Dimer Conformation. J. Virol.
79: 6338-6348
[Abstract]
[Full Text]
-
Paillart, J.-C., Dettenhofer, M., Yu, X.-f., Ehresmann, C., Ehresmann, B., Marquet, R.
(2004). First Snapshots of the HIV-1 RNA Structure in Infected Cells and in Virions. J. Biol. Chem.
279: 48397-48403
[Abstract]
[Full Text]
-
Melamed, D., Mark-Danieli, M., Kenan-Eichler, M., Kraus, O., Castiel, A., Laham, N., Pupko, T., Glaser, F., Ben-Tal, N., Bacharach, E.
(2004). The Conserved Carboxy Terminus of the Capsid Domain of Human Immunodeficiency Virus Type 1 Gag Protein Is Important for Virion Assembly and Release. J. Virol.
78: 9675-9688
[Abstract]
[Full Text]
-
Misumi, S., Morikawa, Y., Tomonaga, M., Ohkuma, K., Takamune, N., Shoji, S.
(2004). Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2gag Peptide. J Biochem
135: 447-453
[Abstract]
[Full Text]
-
Myint, L., Matsuda, M., Matsuda, Z., Yokomaku, Y., Chiba, T., Okano, A., Yamada, K., Sugiura, W.
(2004). Gag Non-Cleavage Site Mutations Contribute to Full Recovery of Viral Fitness in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother.
48: 444-452
[Abstract]
[Full Text]
-
Oshima, M., Muriaux, D., Mirro, J., Nagashima, K., Dryden, K., Yeager, M., Rein, A.
(2004). Effects of Blocking Individual Maturation Cleavages in Murine Leukemia Virus Gag. J. Virol.
78: 1411-1420
[Abstract]
[Full Text]
-
de Oliveira, T., Engelbrecht, S., Janse van Rensburg, E., Gordon, M., Bishop, K., zur Megede, J., Barnett, S. W., Cassol, S.
(2003). Variability at Human Immunodeficiency Virus Type 1 Subtype C Protease Cleavage Sites: an Indication of Viral Fitness?. J. Virol.
77: 9422-9430
[Abstract]
[Full Text]
-
Heath, M. J., Derebail, S. S., Gorelick, R. J., DeStefano, J. J.
(2003). Differing Roles of the N- and C-terminal Zinc Fingers in Human Immunodeficiency Virus Nucleocapsid Protein-enhanced Nucleic Acid Annealing. J. Biol. Chem.
278: 30755-30763
[Abstract]
[Full Text]
-
Hill, M. K., Shehu-Xhilaga, M., Campbell, S. M., Poumbourios, P., Crowe, S. M., Mak, J.
(2003). The Dimer Initiation Sequence Stem-Loop of Human Immunodeficiency Virus Type 1 Is Dispensable for Viral Replication in Peripheral Blood Mononuclear Cells. J. Virol.
77: 8329-8335
[Abstract]
[Full Text]
-
Gao, K., Gorelick, R. J., Johnson, D. G., Bushman, F.
(2002). Cofactors for Human Immunodeficiency Virus Type 1 cDNA Integration In Vitro. J. Virol.
77: 1598-1603
[Abstract]
[Full Text]
-
Pettit, S. C., Gulnik, S., Everitt, L., Kaplan, A. H.
(2002). The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol Cleavage. J. Virol.
77: 366-374
[Abstract]
[Full Text]
-
Hill, M. K., Shehu-Xhilaga, M., Crowe, S. M., Mak, J.
(2002). Proline Residues within Spacer Peptide p1 Are Important for Human Immunodeficiency Virus Type 1 Infectivity, Protein Processing, and Genomic RNA Dimer Stability. J. Virol.
76: 11245-11253
[Abstract]
[Full Text]
-
Shehu-Xhilaga, M., Hill, M., Marshall, J. A., Kappes, J., Crowe, S. M., Mak, J.
(2002). The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein. J. Virol.
76: 4331-4340
[Abstract]
[Full Text]